US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

Human Metapneumovirus (HMPV) is a respiratory virus that may not be on most folk’s radars, but it’s more common than you ...

(Alliance News) - hVIVO PLC on Monday said it has signed a contract with Inhalon Biopharma Inc to test its antiviral candidate to treat respiratory syncytial virus. The London-based contract research ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.

Hospitals in China have been 'overwhelmed' by outbreak says WHO as NHS says people with respiratory symptoms should 'limit ...

A virus rapidly spreading in China is also circulating in the United States, causing concern among health experts.

Human metapneumovirus (hMPV) has been hitting the headlines recently as one of the lesser-known winter illnesses that can ...

In the wake of multiple cases of human metapneumovirus (hMPV) in India, multiple questions about its causes and symptoms seem ...

A 4-year-old boy in Ahmedabad has been diagnosed with human metapneumovirus, increasing Gujarat's cases to eight. The child is in stable condition. The virus, spreading since 2001, resembles the ...

Human metapneumovirus (hMPV) cases continue to be reported in several states across India, although the number of cases is ...

ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defense immune enhancers to minimize the impact of respiratory viral infections in at-risk populations, announces ...

Cases of human metapneumovirus, or HMPV, a contagious virus that can lead to respiratory disease, is reportedly spiking in northern China. Infectious disease experts say risk to the U.S. is low.